dc.contributor.author |
Kirwan, Daniela E. |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.date.accessioned |
2018-12-03T17:02:47Z |
|
dc.date.available |
2018-12-03T17:02:47Z |
|
dc.date.issued |
2018 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/4291 |
|
dc.description.abstract |
During the 19th century a staggering one in four people died from tuberculosis. Incidence steadily declined with socioeconomic improvements and medical advances such that by the 1980s tuberculosis was considered a disease of the past and control measures were relaxed. This approach was premature: rising incidence led WHO to declare tuberculosis a global emergency in 1993. Control efforts were re-intensified and although incidence has now peaked, world population growth means that absolute numbers remain stable. The costs involved are substantial, with an estimated US$6·9 billion spent on global tuberculosis control in 2017,1 yet the effectiveness of available interventions across different populations remains poorly understood... |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Lancet. Public Health |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
false economy |
en_US |
dc.subject |
tuberculosis control |
en_US |
dc.subject |
tuberculosis |
en_US |
dc.title |
A false economy: we cannot afford to be complacent when it comes to Tuberculosis control |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/S2468-2667(18)30019-7 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.05 |
|
dc.relation.issn |
2468-2667 |
|